Boothbay Fund Management’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Sell |
845,391
-97
| -0% | -$218 | 0.04% | 384 |
|
|
2025
Q1 | $1.81M | Buy |
845,488
+300
| +0% | +$642 | 0.05% | 357 |
|
|
2024
Q4 | $2.05M | Buy |
845,188
+16,857
| +2% | +$40.8K | 0.05% | 367 |
|
|
2024
Q3 | $2.02M | Buy |
828,331
+3,333
| +0.4% | +$8.13K | 0.05% | 425 |
|
|
2024
Q2 | $2.12M | Buy |
824,998
+135,249
| +20% | +$348K | 0.05% | 400 |
|
|
2024
Q1 | $2.01M | Buy |
689,749
+164,748
| +31% | +$481K | 0.04% | 428 |
|
|
2023
Q4 | $1.21M | Buy |
+525,001
| New | +$1.21M | 0.03% | 561 |
|
|
2020
Q3 | – | Sell |
-30,963
| Closed | -$109K | – | 1052 |
|
|
2020
Q2 | $109K | Sell |
30,963
-6,110
| -16% | -$21.5K | 0.01% | 749 |
|
|
2020
Q1 | $113K | Buy |
+37,073
| New | +$113K | 0.01% | 620 |
|